leukemia Nov 3, 2022 Kura Oncology Receives $25M Investment From Bristol Myers Squibb; Enters $125M Loan Agreement Nov 1, 2022 OncoPrecision Validating Patient-Derived Functional Drug Screening Platform Oct 31, 2022 Coeptis Merges With SPAC Bull Horn Holdings, Lists on Nasdaq Oct 28, 2022 Gilead Sciences' Oncology Sales Soar 79 Percent in Q3 Premium Oct 27, 2022 Biomea Fusion Begins Dosing CLL Patients in Phase I Trial of BMF-219 Oct 25, 2022 Pluvicto Sales Ramp up, Kisqali Gains Continue in Q3 for Novartis Premium Oct 24, 2022 Invivoscribe Files FDA Supplemental PMA for CDx Test to Select AML Patients for Daiichi Sankyo Drug Sep 19, 2022 CancerRNA Consortium Will Harness RNA Technology to Enhance Immunotherapies Sep 1, 2022 Mission Bio Aims to Establish Proof of Concept for Single-Cell MRD Test in AML Premium Aug 29, 2022 Novartis' Scemblix Nets European Approval for Subset of CML Patients Aug 22, 2022 Kronos Begins Trial of Second SYK Inhibitor in FLT3-Mutated AML Aug 16, 2022 Invivoscribe, Kronos Bio Partner on Companion Diagnostic Test for Leukemia Drug Aug 5, 2022 Chronic Lymphocytic Leukemia Genomic Study Reveals New Subtypes, Ties to Outcomes Aug 3, 2022 Gilead Sciences' Q2 Oncology Sales Jump 71 Percent Driven by Trodelvy, Cell Therapies Premium Jul 28, 2022 Aniling Gets CE-IVD Marks for Cancer Sequencing Tests Jul 25, 2022 Gilead's Tecartus Gets EMA CHMP Recommendation in Advanced ALL Jul 22, 2022 Leukemia and Lymphoma Society PedAL Trial Aims to Advance Pediatric Precision Oncology Premium Jul 13, 2022 Mission Bio Working to Bring Tapestri Single-Cell Sequencing Platform to Precision Oncology Premium Jun 29, 2022 Leukemia and Lymphoma Society Launches Master Protocol Trial in Childhood Leukemia Jun 24, 2022 EMA's CHMP Recommends Novartis' Scemblix for TKI-Intolerant Chronic Myeloid Leukemia Patients Load More Breaking News In Brief This Week: Gilead Sciences, Arcus Biosciences, Verismo Therapeutics, Caris Life Sciences Pyxis Oncology Gets FDA Permission to Start Phase I Trials of Anti-EDB Drug, Immunotherapy FDA Approves Rigel Pharmaceuticals' Rezlidhia for IDH1-Mutant AML Sofie Biosciences to Begin Trial of Fluorine-Labeled PET Diagnostic Imaging Agent for GI Cancers Study Unearths Features Found in Long-Term Survivors of Advanced Ovarian Cancer Carrick Therapeutics Receives $35M Investment From Pfizer; Raises $25M in Series C Funding Round
